CTCAE Grading of New Clinical Toxicity per Patient During the 3 Months After Treatment
| Toxicity | CTCAE grade I | CTCAE grade II | CTCAE grade III | CTCAE grade IV | CTCAE grade V |
| Abdominal pain | 16 | 10 | 4 | ||
| Nausea | 15 | 9 | 2 | ||
| Fatigue | 21 | 10 | 2 | ||
| Anorexia | 10 | 5 | |||
| Dyspnea | 4 | 1 | |||
| Fever | 7 | 1 | 1 | ||
| Ascites | 1 | 2 | |||
| Flulike symptoms | 2 | 1 | |||
| Malaise | 4 | 1 | |||
| Hepatic failure | 1 | 1* | |||
| Weight loss | 2 | ||||
| Chest pain | 1 | 2 | |||
| Vomiting | 9 | 5 | |||
| Dyspepsia | 1 | 1 | |||
| Metal taste | 3 | ||||
| Contrast allergy | 1 | 2 | |||
| Hematoma | 1 | ||||
| Diarrhea | 1 | ||||
| Constipation | 4 | ||||
| Upper gastrointestinal tract bleeding | 1 | ||||
| Limb edema | 2 | ||||
| Dizziness | 1 | ||||
| Chills | 2 | ||||
| Any clinical toxicity | 13 | 19 | 7 | 1 | |
| Lowered albumin | 9 | 4 | |||
| Elevated alanine aminotransferase | 24 | 1 | 1 | ||
| Elevated alkaline phosphatase | 4 | 14 | 2 | ||
| Elevated aspartate aminotransferase | 28 | 2 | |||
| Elevated bilirubin | 2 | 1 | 2 | ||
| Elevated γ-glutamyltransferase | 5 | 15 | 5 | ||
| Any laboratory toxicity | 7 | 23 | 5 | 2 |
↵* Radioembolization-induced liver disease.
Highest CTCAE grades per clinical symptom or laboratory value are represented.